Important ABSTRACT Information ISALXIX, Munich March 16-19, 2025

Call for Abstracts

Below all necessary information and forms with just one click available for saving, downloading, or printing:

Guidelines for the submission of abstracts: Guidelines

The 19th biannual symposium ACUTE LEUKEMIAS (ISALXIX) will be held from Sunday, March 16 to Wednesday, March 19, 2025, in Munich, Germany.

We encourage all colleagues who are interested in actively participating with a free contribution to submit their abstracts. The Scientific Committee will review all abstracts for participation in the on-site Poster Viewing and Discussion Session (MSV) or for oral presentation in Main Session IX (Best of Free Conbtributions Session).



We offer authors the option to publish open access books and chapters in a wide range of areas within science, technology and medicine (STM) and within the humanities and social sciences (HSS).
Open access allows unrestricted online access to your ebook with no reading or subscription fees. Authors retain copyright and are able to comply with funders‘ open access mandates. Our open access academic books and chapters on average receive 10 times more downloads, 2.4 times more citations, and 10 times more online mentions compared to non-open access books. Open access books can have a more geographically diverse readership, reaching on average 61% more countries than non-open access books. Each open access scholarly book or chapter receives the same editorial and publishing expertise, rigorous peer review and high quality production process that non-open access books receive.

For all ISALXIX abstract submitters this new Open access means:
The abstract supplement of the 19th International Symposium ISALXIX – Munich, March 16-19, 2025, published in Annals of Hematology will be freely available to read to everyone – including congress participants of course.

From January 2025 on, SPRINGER will not have any subscription content in the journal anymore, which would be only accessible behind a paywall. From next year on all articles published in the journal will be published under the open access model, meaning everyone around the world has free access to the content published in the journal free of charge.


TOPICS for Free Contributions

Your abstract should cover one of the following topic areas:

  • Leukemic Stem Cells
  • AML – Biology
  • AML – Therapy
  • ALL – Biology
  • ALL – Therapy
  • Pediatric Acute Leukemias
  • Immunotherapy of Acute Leukemias
  • Stem Cell Transplantation
  • Management of Elderly and Frail Patients
  • Supportive Therapy and Quality of Life
  • Leukemia Microenvironment


Submission Deadline, Review Process and Eligibility Criteria for Abstracts

Your abstract should be received via email ( by October 31, 2024 (23:59 CET) on the official abstract form plus the filled-in and signed SPRINGER Conflict of Interest Disclosure Form.


Each abstract will be reviewed by at least three independent scientific reviewers from the International Scientific Committee according to the following 6 eligibility criteria:

1) background and rationale for study

2) appropriateness of methods

3) presentation of results

4) conclusions and interpretations of results

5) significance and

6) overall clarity


Acceptance of Abstracts

Notification of acceptance of your abstract for poster presentation and for publication in the symposium proceedings ISALXIX in ANNALS OF HEMATOLOGY will be received by January 15, 2025 (23:59 CET).


Abstracts will only be accepted provided they meet the above eligibility criteria

–       for publication in the symposium proceedings and

–       for presentation in poster session MS V on Monday, February 17, 2025 (in-person).


Instructions for the Participation in On-Site Poster Session (MSV)

MONDAY, March 17, 2025: 16:00 – 18:00 (CET) (MS V: ON-SITE Poster Viewing and Discussion Session)

For participation in the on-site Poster Session MS V on Monday, March 17, 2025 between 16:00 and 18:00 (CET) your poster has to be mounted during the official ISALXIX opening hours. To give the Poster Committee members the possibility to preview the posters and to be eligible for one of the below mentioned awards and prizes your poster must be mounted until Monday, March 17, 2025 (13:00 CET) at the latest. Failure to meet the above mentioned deadlines will result in the complete removal of presenting privileges and will appear as “Presentation not Available”

Posters will be presented on the Upper Floor of the symposium venue. All poster presenters are being asked for their in-person presence in front of their poster/s to allow all participants and members of the jury to talk to the presenters and have a personal scientific exchange about their poster(s).


Poster Awards

The ISALXIX organizers are pleased to offer again all accepted poster applicants to be eligible for one of the following awards:

2 Poster Awards (PA):

Each award will be awarded a prize of € 500

3 Best-of-Free-Contributions Awards (BoFCA):

These awards will be granted to young scientists whose abstract has been accepted for presentation in the poster session.


Registration Deadline for Poster Presenters

To be accepted for poster presentation and publication in Annals of Hematology, all accepted presenters must be officially registered and have paid their registration fees by January 31, 2025.


ISALXIX Encore Abstract Policy

ISALXIX Munich March 16-19, 2025 welcomes the submission of abstracts which have been previously presented at national, regional or international meetings in the two years preceding the symposium.

Encore abstracts must however clearly be documented and identified as such at the time of submission. To be eligible and accepted, the encore abstract must be updated and include significant additional current data to distinguish itself from the previous presentation/s.

Submission will not be permitted if a manuscript has been published before.


ISALXIX Late-Breaking Abstract Policy

Late-breaking abstracts may be submitted for high quality, new research findings with major impact on clinical practice or the understanding of disease processes. The abstract must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organization prior to ISASLXIX March 16-19, 2025.

Only abstracts for which no data of evidential value have been available at the time of the official regular abstract submission deadline of December 31, 2024 (23:59 CET) will be considered for late-breaking status.

The late-breaking abstract submission site will open from Wednesday February 26, 2025 through Wednesday March 5, 2025.

The deadline of March 5, 2025 for late-breaking abstract submissions is under no circumstances to be considered as an extension of the above mentioned regular submission deadline of December 31, 2024 (23:59 CET).

Late-breaking submitted abstracts that do not meet the above mentioned criteria will not be accepted for poster discussion or oral presentation.

Late-Breaking Abstract Submission Instructions and Review Process: Guidelines for the submission of abstracts: Late-Breaking Abstract

The abstract must include the title, first author (with full contact details), objectives, rationale, methodic procedure and anticipated data. Please see all further details for the abstract in the general abstract guidelines.

The ISALXIX 2025 Scientific Committee will review all abstracts indicated as late-breaking and first authors will be notified whether the submitted work has been accepted as a late-breaking abstract for the presentation

–       at the ISASLXIX Poster Presentation and Discussion Sessions MS V and/or

–       as an oral presentation in the Prize Giving (MS IX)

Late-Breaking Abstract Submission and Symposium Proceedings

Since the submission deadline at SPRINGERs for all included contributions in the symposium proceedings is January 15, 2025, accepted late-breaking submitted abstracts cannot be included in the ISALXIX symposium proceedings published in ANNALS OF HEMATOLOGY.

Notification about Acceptance of Late Breaking Abstracts

Notification about acceptance of the submitted late breaking abstracts will be received until Monday, March 8, 2025.


Registration Deadline for Late Breaking Abstract Submitters

To be included in Poster Sessions MS V all presenters of a late breaking abstract must be officially registered and have paid their registration fees by March 10, 2025.


Abstract Submission Deadlines at a Glance:

Abstract Submission Deadline: October 31, 2024 (23:59 CET)

Submission Deadline for Encore Abstracts: Oktober 31, 2024 (23:59 CET)

Submission Deadline for Late-Breaking Abstracts: February 22, 2025 (23:59 CET)


All abstract submissions must be made electronically

and have to be sent to